> Go back to Families
DONATE NOW
> Go back to Parent Support
> Go back to Parent Support
About Us
MPS Society
Transforming lives through
support, research and awareness
DONATE
SHOP
E-NEWS
About us
Who we are
Our promise
Our friends
Our vision
News
What's new
Work with us
Support we offer
How COVID-19 affects you
COVID-19: resource list
Parent support
Adult and young people support
Sibling support
Bereavement and palliative care
Support events and clinics
Sensory workshops
Parents workshop
Our resources
Disability Living Allowance
About the diseases
MPS diseases
Fabry disease
Related diseases
Treatments and research
Family stories
Get involved
Fundraise
Captain Tom 100 Challenge
MPS Awareness Week
Fundraising events
Community
Support us at work
Fundraising resources
Volunteer with us
Leaving a legacy
In memory
How your money helps
More
News
Vimizim update from NICE for MPS IVA (Morquio)
New COHERE study for MPS II patients
MPS Society's chance to win £1,000
What's new for Sophie?
Welcome Mandy who start in a brand new role at the MPS Society
Conference 2021 Announcement
National Lottery Community Fund award £195K to build connections and reduce feelings of isolation
Understanding Fabry patients and their interest in future therapies
MPS Society welcomes new UK Rare Diseases Framework
Treatment for Metachromatic Leukodystrophy (MLD) approved by the European Commission
Latest information for clinically extremely vulnerable adults and children
Kelly Mills' charity appeal for MPS Society on Radio 4
AVROBIO announce collaborative research agreement with Manchester university for MPS II gene therapy
REGENXBIO announces expansion of gene therapy programme for the treatment of MPS II
Tune in to Kelly Mills' charity appeal for MPS Society on Radio 4 this month
Ross Kemp's Living With Dementia series visits a family affected by Sanfilippo
Impact report 2019/20
Brain disease treatment shows promising signs
NHS England and shielding (updated 24 June 2020)
Paediatric advice on clinical support and homecare (updated 26 March)
Changes to our service as a result of COVID-19
MPS Society response to Budget announcement
Advice for patients, parents and guardians on inherited metabolic disease and Coronavirus (COVID-19)
Vimizim re-evaluation process suspended - NICE's statement and MPS Society's response
